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The Influence of Demographic and Socioeconomic Factors on the Appropriate Use of 
Aspirin Therapy 
Abstract 
 Existing research has shown aspirin therapy to be an effective preventive 
measure for cardiovascular disease in both individuals who have experienced a previous 
cardiovascular event and in those that are at an elevated risk to do so.  Both the 
American Heart Association and the United States Preventive Services Task Force have 
recommended regular aspirin therapy for all individuals with existing cardiovascular 
disease, as well as individuals who present an elevated risk for a future cardiovascular 
event.  However, existing research suggests that the actual use of aspirin as a preventive 
treatment is alarmingly low, and may be affected by age, race, gender, and 
socioeconomic status.  In this study, the influence of demographic and socioeconomic 
factors on the effective use of aspirin as a preventive treatment for cardiovascular 
disease was examined.  Results suggest that while women and younger individuals do 
use daily aspirin to a lesser extent, they are actually more likely to follow the proper 
course of preventive action according to established guidelines.  Race and income 
influenced the use of aspirin therapy to a lesser extent than in other studies, and this 
lends support to the theory that quality of medical care is a source of the socioeconomic 
difference in preventive medicine.  Results identify specific groups of individuals that 
may benefit from aspirin intervention and education programs. 
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 The use of aspirin therapy in the prevention of cardiovascular disease has been 
shown to be an effective and beneficial treatment (Berger et al. 2006).  For individuals 
with existing cardiovascular disease, aspirin therapy used as secondary prevention has 
been shown to reduce the reoccurrence of strokes and myocardial infarction by 30%, 
while also reducing all-cause mortality by 18% (Weisman and Graham 2002).  It has 
been shown to significantly decrease the occurrence of myocardial infarction in men 
and the occurrence of ischemic stroke in women, with effectiveness of treatment 
increasing with age.  Aspirin therapy is one of the more affordable preventive 
treatments available, and shows great benefit when compared to possible risks (Greving 
et al. 2008).  The American Heart Association and American College of Cardiology 
recommends that all individuals with existing cardiovascular disease take a low-dose 
(75-162mg) aspirin daily for prevention of future cardiovascular events (Smith et al. 
2006).  While the use of aspirin for primary prevention of cardiovascular disease is less 
common than for secondary prevention, research supports the use of aspirin for both 
types of prevention.  Studies have demonstrated that benefits of a reduction in 
myocardial infarction and stroke outweigh the small chance of non-fatal internal 
bleeding for primary prevention individuals at medium or high risk for cardiovascular 
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disease (Weisman and Graham 2002).  And yet, people are not utilizing this cost-
effective and evidence-backed method of cardiovascular disease prevention.   
Research suggests that many doctors may not be aware of the proven benefits of 
aspirin therapy or may be wary of its side effects (Stafford and Radley 2002).  Higher-
income individuals are more likely to receive care at academic medical centers 
practicing evidence-based medicine, and patients at academic medical centers are more 
likely to receive aspirin therapy during inpatient care followed by a recommendation to 
continue therapy after discharge (Rao et al. 2004).  The socioeconomic divide in access 
to quality healthcare may influence the use of aspirin in lower-SES individuals.  Many 
may incorrectly assume that aspirin therapy is effective only for men, even though 
research has demonstrated significant benefit for both men and women (Greving et al. 
2008).  With regard to race, African Americans have been shown to have far greater 
short-term and long-term mortality rates after acute myocardial infarction, but are 
using aspirin therapy much less than white persons (Rao et al. 2004).  Age has also been 
shown to be an important factor in the effectiveness of aspirin therapy; the older the 
individual, the more effective aspirin therapy is for the reduction of cardiovascular 
events (Greving et al. 2008).  Aspirin therapy is less likely to be used by women, younger 
individuals, low-income and low-educated individuals, and non-white persons (Rolka et 
al. 2001).  Many of these demographic and socioeconomic factors are interrelated and 
may be explained through the Health Belief Model (NCI 2005).  This model is based on 
the idea that a person will engage in preventive medicine only after passing through a 
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certain criteria of action.  The purpose of this study is to explore how differences in 
socioeconomic and demographic factors affect an individual’s appropriate use of aspirin 
therapy.  This study aims to explore the relationships between age, gender, race, 
income, and education that determine an individual’s use of prescribed and appropriate 
(following established guidelines of use) aspirin therapy, and possible causal 
mechanisms of existing socioeconomic or demographic differences through the Health 
Belief Model.   
 
Benefits and Risks of Aspirin Therapy 
 The benefits of aspirin therapy for individuals with existing cardiovascular 
disease are well accepted.  In a meta-analysis of six clinical trials, Weisman and Graham 
(2002) found a statistically significant reduction of all-cause mortality of 18% for 
individuals using daily aspirin therapy.  The results also showed a reduction in the 
frequency of vascular events and myocardial infarction by 30% (Weisman and Graham 
2002).  This benefit seemed to be present at very low doses of aspirin (30-75 mg/day), 
and the effectiveness of treatment remained the same with higher dosages (Hopkins 
and Limacher 2008).  The risk of gastrointestinal bleeding, however, did increase with 
dose by a factor of 1.5 to 2.0 during the use of aspirin therapy (Persell and Baker 2004).  
Gastrointestinal bleeding was still rare (only 58 cases reported out of 6300 total 
participants), and there were no deaths reported (Weisman and Graham 2002).  
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Hopkins and Limacher (2008) estimated that approximately 10% of the population may 
be intolerant to aspirin due to an allergic reaction or other upper-respiratory problems.  
For secondary prevention, the benefits clearly outweigh the risks, and for these reasons 
the American Heart Association and American College of Cardiology recommended all 
secondary prevention individuals to follow a low-dose aspirin regimen (Smith et al 
2006). 
 The benefits of aspirin use for primary cardiovascular prevention, however, have 
only recently been demonstrated consistently.  As a result, secondary prevention 
individuals were found to be 4.3 times more likely to use aspirin therapy than primary 
prevention individuals (Rolka et al 2001).  A meta-analysis of six trials exploring aspirin 
use in primary cardiovascular prevention found that aspirin significantly reduced the risk 
of a cardiovascular event, but also increased the likelihood of non-fatal gastrointestinal 
bleeding (Berger et al, 2006).  After assessing benefits against risks, Greving et al (2008) 
concluded that aspirin therapy was beneficial for all men over 55 years old, as well as for 
women 55 years or older who have several risk factors for cardiovascular disease.  While 
the benefits of aspirin therapy in primary prevention may not outweigh the risks of 
serious bleeding events for all individuals, research supports that a great deal of primary 
prevention individuals may benefit from it.  In 2009, the United States Preventive 
Services Task Force recommended that primary prevention individuals, including men 
age 45-79 and women age 55-79 with a cardiovascular disease risk that outweighs the 
risk of serious bleeding events, follow an aspirin regimen (USPSTF 2009).  These 
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guidelines have specific risk thresholds for each age and gender category, and can be 
found in Figure 1. 
 
Theoretical Framework 
 The Health Belief Model is very useful in exploring the existing divides along 
socioeconomic lines in effective aspirin use.  It contains a series of six criteria that must 
be fulfilled for an individual to take preventive action (NCI 2005).  The six criteria are a 
perceived susceptibility (beliefs that a person may contract a condition), perceived 
severity (beliefs that a condition would have serious or harmful effects), perceived 
benefits (belief that taking preventive action would reduce chance of contracting 
condition or its effects), perceived barriers (belief that costs of preventive measures are 
less than perceived benefits), cues for action (exposure to a stimulus for taking action), 
and self-efficacy (confidence in one’s ability to take action) (NCI 2005).  These categories 
can also be found in Figure 2.  This model provides potential reasons why demographic 
or socioeconomic factors may limit certain groups of people from taking preventive 
action against cardiovascular disease in the form of aspirin therapy. 
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Gender Disparities 
 One of the main existing disparities in aspirin use is between men and women.  
Existing research suggests that aspirin may operate in different ways for men and 
women, resulting in different treatment patterns and benefits for each.  Previously, it 
was believed that aspirin therapy was less effective for women than men.  The primary 
biological role of aspirin for cardiovascular prevention is to inhibit platelet aggregation 
in blood by acetylating COX-1 and halting a conversion to a platelet activator (Becker et 
al. 2006).  A study by Becker et al (2006) examined the platelet reactivity in both men 
and women on aspirin therapy.  The study found that while women had higher initial 
platelet reactivity, they actually received a greater platelet activity reduction than men, 
with final levels of activity only slightly higher than men’s.  More importantly, both men 
and women had near complete suppression of the COX-1 pathway, suggesting that 
aspirin therapy may be just as effective biologically for women as it is for men (Becker et 
al. 2006). 
 Research into the clinical results of aspirin therapy support the findings of 
positive outcomes for both genders, but the specific benefits differ.  Berger et al (2006) 
found through a meta-analysis of six aspirin trials that men and women both received 
measureable benefit from aspirin therapy as demonstrated by an overall reduction of 
cardiovascular events.  While men had a reduced risk of myocardial infarction, woman 
had a lower risk of ischemic stroke during aspirin therapy.  There was no reduction in 
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the risk of myocardial infarction for women or ischemic stroke for men.  A study by 
Hopkins and Limacher (2008) supported these findings of reduced myocardial infarction 
in men and ischemic stroke in women.  Aspirin therapy has also been shown to reduce 
the risk of colorectal cancer in women, and long-term use even shows a moderate 
reduction in death from lung and breast cancer in women (Chan et al. 2007).  Research 
suggests that aspirin therapy is cost-effective for men with a cardiovascular disease risk 
of greater than 10%, and women with a cardiovascular disease risk of greater than 15% 
(Greving et al. 2008).  Men reach these cardiovascular disease risk thresholds at an 
earlier age, so it becomes clear that a differential prescription pattern is necessary for 
aspirin treatment between genders (Murasko 2006).   
 Research demonstrates the benefits of aspirin therapy for both men and women, 
yet a large gap exists in its use.  Multiple studies have shown that men use aspirin 
therapy at a far greater rate than women for primary and secondary prevention (Cho et 
al. 2008; Rolka et al. 2001; Persell and Baker 2004).  Some of these differences may be 
due to the normal prescription pattern of aspirin; women develop cardiovascular 
disease at later ages than men (Murasko 2006).  The greater frequency of aspirin 
resistance found among women may be another factor in this disparity (Berger et al. 
2006).  Access to health insurance has also been shown to have a greater impact on 
women’s rates of preventive screenings and physician contact than men’s (Murasko 
2006).  A study by Mosca et al (1998) suggests that men and women have different 
lifestyle barriers in cardiovascular disease prevention.  Time was the largest barrier to 
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preventive medicine for men, and self-esteem was the largest barrier for women.  The 
Health Belief Model criterion suggests the general population may not be aware of the 
latest research that demonstrates the benefits of aspirin therapy for women and may 
not believe that women would get the same benefits as men (lack of perceived benefits).  
Also, non-evidence-based practitioners may not be as knowledgeable of current 
research in aspirin therapy, and may be less likely to prescribe aspirin therapy (cues to 
action).  Women are more likely to have a lower income than men, and lower-income 
individuals are more likely to go to non-evidence based practices, so the trend of the 
under-prescription of aspirin between genders may be explained by these factors (Rao 
et al. 2004). 
 
Age Disparities 
 Age is associated with gender in determining the effectiveness of aspirin 
therapy.  For primary prevention individuals, aspirin therapy has been shown to be 
effective for all men 55 years or older, due to the prevalence of cardiovascular risk 
factors at that age (Greving et al. 2008).  Women encounter these risk factors at later 
ages on average, and aspirin therapy has been shown to be effective only for women 55 
years or older who also present with multiple risk factors for cardiovascular disease, 
such as smoking, family history of cardiovascular disease, diabetes, hypertension, or 
high cholesterol (Greving et al. 2008; Hopkins and Limacher 2008).  In both genders, 
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greater age increases the prevalence of cardiovascular disease risks, and therefore the 
potential effectiveness of aspirin therapy. 
 Younger individuals have been shown to be much less likely to use aspirin 
therapy than older individuals (Rolka et al. 2001).  Sociological research suggests that 
the primary disparity in aspirin use may be among young men, despite the infrequent 
prescription of aspirin for primary prevention among young women.  Studies suggest 
that men are less likely to engage in help-seeking behavior, and are less likely to go to 
doctor’s offices when sick compared to women (Galdas et al. 2005).  This behavior may 
lead to fewer recommendations for aspirin therapy by physicians for younger men with 
multiple risk factors, because fewer trips to the doctor may result in fewer cues for 
action.  Also, research suggests that socialized masculinity in men leads to a stronger 
belief of immunity to disease or injury, as reflected in men’s tendency to engage in 
much more high-risk behaviors than women (Cherpitel and Ye 2008).  The Health Belief 
Model criterion suggests that younger men may believe that they are less susceptible to 
disease (perceived susceptibility).   
 
Socioeconomic Disparities 
 Income level and education may influence the use of aspirin therapy, with lower-
income and lower-educated individuals using aspirin at a lower rate than the rest of the 
population (Rolka et al. 2001).  Individuals with lower incomes have a much greater all-
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cause mortality rate after discharge from an acute myocardial infarction, both short and 
long term (Tonne et al. 2005).  This result was consistent for both individual income 
levels and individuals living in overall lower-income neighborhoods (Tonne et al. 2005).  
Those with less education were also found to have greater all-cause mortality after a 
myocardial infarction (Gerber et al. 2008).  Lower-income individuals were found to 
present with cardiac disease symptoms later, were less likely to receive evidence-based 
medicine, and were less likely to receive aspirin therapy while hospitalized or receive a 
recommendation to use aspirin after discharge (Rao et al. 2004).  Higher-income 
individuals were more likely to be admitted to teaching hospitals where evidence-based 
medicine was practiced, and were more likely to receive recommendations for aspirin 
therapy upon discharge.  Another disparity in quality of care through socioeconomic 
status was found in smoking cessation rates.  Although low-SES individuals were found 
to have higher rates of smoking (a cardiovascular risk factor), they often received less in-
patient smoking cessation counseling than high-SES individuals (Rao et al. 2004).   
 From existing evidence, the primary disparity in aspirin use among 
socioeconomic status levels seems to be the quality of hospital care and lack of 
evidence-based medicine available to low-SES individuals.  Some may point to an 
inability to afford aspirin therapy, but this has not been demonstrated in clinical studies.  
Aspirin therapy can be quite affordable, costing as low as $1.50 per month; this should 
not provide a large barrier to low-SES individuals who wish to engage in preventive 
aspirin therapy (Rolka et al. 2001).  Since physicians in non-evidence-based medicine 
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practices may be less knowledgeable of current aspirin research, they may be less likely 
to prescribe it based on outdated concerns about its effectiveness (Stafford and Radley 
2003), which may lead to less prescribing of aspirin therapy to low-SES individuals (less 
cues for action).  Moreover, lower-income individuals have generally poorer overall 
health, and may feel they do not have as much control over their health as those with 
higher-incomes.  Due to this, lower-income individuals may not feel aspirin therapy 
would be effective in preventing disease (perceived benefits).  A study by Link, 
Northridge, Phelan, et al. (1998) lends support to this theory.  They found that women 
with higher levels of income and education were more likely to use preventive screening 
such as pap smears and mammograms.  They argue in their fundamental cause of 
disease theory that socioeconomic status is the fundamental cause of risk factors 
associated with disease, and prevails in all societies.  Socioeconomic status may inhibit 
preventive action through the quality of medical care available to low-SES individuals. 
 
Racial Disparities 
 Race is also an important factor in assessing population health and preventive 
medicine effectiveness.  African Americans have much higher short- and long-term 
mortality rates after the occurrence of a myocardial infarction compared to other racial 
groups, regardless of income or education level (Rao et al. 2004).  African Americans are 
especially affected by strokes, and aspirin therapy has shown to significantly reduce the 
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frequency of ischemic stroke (Gorelick et al. 2003).  White persons, however, are 2.5 
times more likely to follow an aspirin regimen than African Americans (Rolka et al. 
2001).  To explain this difference, Underwood (1992) evaluated preventive cancer 
behaviors in black men, and found that there was a high degree of “learned 
helplessness”; black men felt that the high-risk behaviors in which they engaged did not 
have a bearing on their risk for disease and that they were helpless to change their 
individual disease outcomes.  The Health Belief Model criterion of perceived benefits 
may explain why; they do not feel that taking preventive action would lessen the chance 
of contracting a disease or condition. 
 
Summary 
 Research suggests that many of these demographic and socioeconomic 
characteristics are interrelated, so assessing these factors together may offer insight 
into the discrepancies in aspirin use for cardiovascular prevention.  Studies have 
demonstrated that low-SES individuals were more likely to be women, black, younger, 
and have more cardiovascular risk factors present than high-SES individuals (Rao et al. 
2004).  Trends in aspirin therapy show that individuals who were women, younger, black 
or low -SES were all much less likely to follow an aspirin regimen (Rolka et al. 2001).   
The combination of these demographic factors may influence the quality of 
medical care, and a perception of fewer benefits from aspirin therapy.  Research 
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suggests that a lack of perceived benefits and lack of cues for action may account for 
differences in aspirin use along socioeconomic and demographic lines.  The lack of 
perceived benefits may lead to an inaccurate perception of an individual’s actual cardiac 
risk.  This study aims to explore how these demographic trends are related to effective 
and appropriate use of aspirin, and to determine specific groups that may benefit from 
social programs that would educate and encourage the use of aspirin therapy. 
 
 
Methods 
 This study was approved by the Ohio State University Biomedical Institutional 
Review Board.  Survey methods of data collection were used to assess cardiovascular 
risk in a primary care practice population.  The sample population was the family 
practice patients of the Ohio State University Primary Care Network located around the 
Columbus city area and surrounding communities.  This population was chosen because 
the prescription of aspirin therapy usually occurs during preventive medical care, which 
occurs most frequently in the primary care setting.  The survey contained a variety of 
questions about cardiovascular risk factors (smoking status, family history, diabetes, 
hypertension, high cholesterol, kidney disease), aspirin use (frequency, dosage, reasons 
for following/not following an aspirin regimen, physician recommendation of aspirin), 
and demographic information (age, gender, ethnicity, race, level of education,  income).  
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After participants completed the survey, clinical information (latest blood pressure, lipid 
profile, glucose level, hemoglobin A1c level, and C-reactive protein) was obtained from 
the participants’ medical records to accurately calculate cardiovascular disease risk 
using the Framingham cardiovascular risk assessment tool.  The surveys were 
distributed through a convenience sample to 50% of the incoming practice population in 
the waiting area.  The target population was limited to adults 40 to 80 years of age.  
Individuals were excluded from the study if they could not read or comprehend English.   
 The surveys were administered from July through October 2008.  After survey 
collection was complete, the data was entered into a computer database in March 2009, 
and the data was analyzed in April 2009.  Descriptive statistics and cross-tabulations 
were performed in SPSS 17.0.  Significance of correlations was tested with chi-squared 
analysis and Fisher’s exact testing.  The Framingham cardiovascular risk assessment tool 
was used to evaluate cardiovascular risk, and the clinical risk was categorized “should 
take aspirin” or “should not take aspirin” in accordance with USPSTF guidelines as listed 
in Figure 1 (USPSTF 2009).  The demographic and socioeconomic data was compared to 
each of three dependent variables in cross-tabulation; (1) daily aspirin use, (2) following 
a healthcare provider’s recommendation for aspirin therapy, and (3) the appropriate use 
of aspirin therapy according to USPSTF guidelines. 
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Results 
Characteristics of Sample 
 There were 917 total surveys administered in the study.  The breakdown of 
demographic characteristics mirrored the known population of the Ohio State primary 
care network.  Of the respondents, 332 (36.2%) were men and 584 (63.7%) were 
women.  The age of the respondents ranged from 40 to 80 years of age; the mean age 
was 54.8 years, while the median age was 54 years old.  The racial distribution of 
respondents included 597 (65.1%) white respondents, and 251 (27.4%) black 
respondents.  Due to a lack of respondents from other racial categories, only these two 
racial categories were used in data analysis.  The median level of education for the 
sample was some college education, with 296 (32.3%) participants reporting an 
education of a high school degree or less, and 608 (66.3%) reporting an education of 
some college education or a college degree.  The distribution of annual household 
income included 325 (35.4%) respondents reporting less than $24,000, while 530 
(57.8%) respondents reported an annual household income of $24,000 or greater.  The 
majority (562, 61.3%) of respondents reported private health insurance, while 127 
(13.8%) respondents reported using Medicare, 173 (18.9%) used Medicaid or Care 
Source, and only 26 (2.8%) were self-pay or uninsured.  The demographic characteristics 
of the sample can be found in Table 1.  
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Demographic and Socioeconomic Correlations to Aspirin Use 
 Demographic characteristics of the sample were first examined individually to 
determine their correlations to daily aspirin use.  358 (39.3%) of all respondents 
reported daily aspirin use.  Men were found to be 8.2% more likely to use aspirin 
therapy than women (p < 0.01).  Black respondents were 3.3% more likely to use daily 
aspirin therapy than white respondents but this was not statistically significant.  Age 
correlated with daily aspirin use, with 63.9% of respondents age 65 to 80 reporting daily 
aspirin use compared to only 26.5% of respondents age 40 to 54 (p < 0.01).  
Respondents who did not receive a high school diploma used aspirin therapy least often 
(33.3%), but this was not statistically significant.  Income level was significantly 
associated with daily aspirin use (p < 0.01).  Respondents reporting annual household 
incomes of less than $24,000 were significantly more likely to use daily aspirin therapy 
(44.6%) than respondents with annual household incomes of $24,000 or more (35.9%).  
Health insurance was significantly associated with daily aspirin use; individuals on 
Medicare reported much higher rates of daily aspirin use (57.8%) than individuals on 
other forms of insurance.   
Two other categories were also examined for daily aspirin use.  The influence of 
prevention category (respondents with no history of cardiovascular disease were 
defined as primary prevention, and respondents with a history of CVD were defined as 
secondary prevention), and the respondent’s perceived risk of having a heart attack or 
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stroke within ten years were both compared to daily aspirin use.  Secondary prevention 
individuals were found to use aspirin therapy at a higher rate (64.5%) than primary 
prevention individuals (30.0%) (p < 0.01).  Perception of risk also had a significant impact 
on an individual’s use of aspirin therapy, with 47.7% of individuals reporting a perceived 
high risk taking aspirin compared to only 33.2% of individuals reporting a perceived low 
risk of cardiovascular event (p < 0.01).  These findings and chi-squared values are 
summarized in Table 2. 
 
Correlations to Provider’s Recommendation for Aspirin Therapy 
In further analysis, the reported daily use of aspirin was compared to the 
reported recommendation by the respondent’s healthcare provider to follow or to not 
follow a daily aspirin regimen, as demonstrated in Table 3.  84.2% (691) of respondents 
were following the course recommended to them by their physician.  These results were 
consistent between genders (84.1% of men; 84.2% of women), education levels (all 
categories were between 80.3% and 88.1%), and annual income levels (84.5% for 
respondents with an income of less than $24,000; 84.5% for respondents with an 
income of $24,000 or greater).  White respondents followed their healthcare provider’s 
recommendation at a higher rate (85.9%) than black respondents (79.9%) (p < 0.05).  
Younger respondents were more likely to follow a physician’s recommendation (p < 
0.05); 86.6% of individuals age 40 to 54 reported following a provider’s 
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recommendation, while only 77.6% of respondents age 65 to 80 did so.  Individuals with 
private insurance were more likely to follow a provider’s recommendation (85.6%) than 
respondents who were on Medicaid (81.9%), Medicare (81.1%), or did not have medical 
insurance (78.3%).  These differences, however, were not statistically significant.  
Prevention category or perceived risks of a cardiovascular event were not significantly 
associated with an individual’s likelihood to follow physicians’ recommendations for 
aspirin therapy.   
 
Correlations to Appropriate Aspirin Use 
 The demographic and socioeconomic factors were compared to the appropriate 
use of aspirin therapy according to the United States Preventive Services Task Force 
recommendations for aspirin use (all secondary prevention individuals, all primary 
prevention individuals with a cardiovascular disease risk that outweighs the risk of 
serious bleeding events, as outlined in Figure 1).   63.1% of all respondents were found 
to be following USPSTF guidelines for appropriate aspirin use.  Women (68.5%) follow 
these recommendations at a greater rate than men (54.2%) (p < 0.01).  White 
respondents follow USPSTF guidelines (64.5%) more than black respondents (60.3%), 
although this difference was not statistically significant.  Younger individuals follow 
USPSTF guidelines at a greater rate than older individuals, but this difference was not 
significant.  Data suggests an association between higher education and USPSTF 
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guidelines compliance, but the results were not statistically significant.  When the 
education categories were categorized as “high school degree or less” and “some college 
/ college degree”, respondents with a high school education or less (58.0%) followed 
USPSTF aspirin use guidelines at a significantly lower rate than individuals with some 
college or a college degree (66.5%) (p < 0.05).  Respondents with an annual income of 
$24,000 or greater follow USPSTF guidelines at a higher rate (66.1%) than respondents 
with an annual income of less than $24,000 (62.0%), but this difference was not 
significant.  There was no significant correlation in health insurance type to appropriate 
aspirin use.  Secondary prevention respondents follow USPSTF guidelines (64.8%) more 
than secondary prevention respondents (62.4%), although this difference was not 
significant.   A respondent’s perceived risk of a cardiovascular event was not significantly 
associated with a respondent’s compliance to USPSTF guidelines for aspirin use.  These 
findings and chi-squared values are summarized in Table 4. 
 
Discussion 
 Many of the findings from this study are consistent with many demographic and 
socioeconomic trends demonstrated in literature, but also produced some new and 
conflicting perspectives on the association between demographic and socioeconomic 
factors with aspirin use.  Daily aspirin use was found to be significantly more common in 
men, older, and secondary prevention individuals, which was consistent with previous 
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literature (Rolka et al. 2001).   However, prescribed aspirin use and appropriate use of 
aspirin according to USPSTF guidelines as additional dependent variables provided 
interesting contrasts to these findings. 
 With regard to gender, men were found to use aspirin at a higher rate than 
women, but both genders followed the recommendation of their health care provider at 
similar rates, and women were actually more likely to follow USPSTF guidelines for 
aspirin use.  These results are represented in Figure 3.  These findings suggest that while 
previous research focuses on the gender disparity in aspirin use, men may still benefit 
from increased education regarding aspirin use for cardioprevention.  Women have 
been shown to develop significant cardiac risk at a later point in life than men, and men 
in general are at a higher risk of cardiovascular disease, a gender disparity in aspirin’s 
use may be a logical conclusion (Greving et al. 2008).  More importantly, women were 
more likely to follow established guidelines for aspirin use, which suggests that men are 
lagging behind women in cardiovascular disease prevention through aspirin use.  The 
Health Belief Model criterion of cues to actions may help to explain this disparity.  
Generally, men have been found to be less likely to engage in help-seeking behaviors 
(Galdas et al. 2005).  In a survey of family physicians, Tudiver and Talbot (1999) found 
that physicians believed men were much more indirect about the problems for which 
they came to visit their doctor.  Men were also more likely to see their doctor for a 
specific problem, while women were more likely to come into the office for general 
health concerns, such as preventive medicine.  This would result in fewer cues for 
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action, because men would be less likely to come into a visit for preventive concerns, or 
would be less direct about their preventive medicine concerns.  These findings suggest 
that future research to evaluate potential problems that men have with establishing and 
confronting preventive medicine would be beneficial. 
  The study results of increasing use of aspirin with age are consistent with existing 
research; aspirin has been found to be more effective in preventing cardiovascular 
events with increasing age, and, on average, more cardiac risk factors are present with 
increasing age (Greving et al. 2008).  This study revealed that younger individuals were 
more likely to follow the recommendation of their health care provider.  Because of the 
prevalence of cardiac risk factors in the elderly, especially in elderly men, these findings 
highlight a major area of concern for preventive medicine.  Older men have been shown 
to be the most at risk for a cardiovascular event, yet they have been shown to be the 
least likely to follow the proper course of action in aspirin therapy (Greving et al. 2008).   
 This study also revealed that respondents with an annual income of less than 
$24,000 were more likely to use daily aspirin therapy than individuals with an annual 
income of $24,000 or greater.  This finding is opposite of the SES gradient in literature.  
This finding reinforces the affordability of aspirin as an affordable method of prevention, 
even for those with low incomes (Rolka et al. 2001).  Previous research suggests that the 
disparity in aspirin use between income levels was due to the lack of evidence-based 
medicine and differences in quality of medical care.  In this study, all respondents 
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surveyed were patients in the same network of evidence-based practices; perhaps the 
primary cause of the SES disparity of aspirin use was not present in this study population 
(Rao et al. 2004).  Respondents with higher incomes were more likely to use aspirin 
therapy in accordance with USPSTF guidelines than lower income respondents, but this 
difference was not significant.  Education was significantly associated with USPSTF 
guideline compliance but was not significantly associated with the use of aspirin therapy 
or the likelihood of following a health care provider’s recommendation.  Consistent with 
previous studies, respondents with a high school education or less were less likely to 
follow aspirin therapy guidelines than respondents with some college education or a 
college degree.  When examining education and income together as a measure for 
socioeconomic status, findings suggest the absence of group differences, which may be 
the result of equitable health care quality provided through a primary care network 
utilizing evidence-based medicine.  This result may support further research into the 
differences in quality of health care and preventive medicine in non-evidence-based 
medical care. 
Racial disparities in aspirin use were also demonstrated, although they were not 
as pronounced as literature suggests.  While black persons were more likely to use 
aspirin therapy, white persons were more likely to follow a healthcare provider’s 
recommendation, and were more likely (although not statistically significant) to follow 
USPSTF guidelines.  These findings support existing research which suggests African 
Americans may benefit from interventions to increase appropriate aspirin use (Rolka et 
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al. 2001).  A possible explanation for the greater use of aspirin therapy by black persons 
is that the disparity exists through socioeconomic status, and subsequent use of non-
evidence based medicine.  Further comparison between racial groups while controlling 
for income levels may be useful in evaluating this explanation.  The Health Belief Model 
criterion of perceived benefits of aspirin therapy may not have been demonstrated due 
to the “learned helplessness” in health prevention behaviors described by Underwood 
(1992). 
 Primary prevention respondents were less likely to follow an aspirin regimen 
than secondary respondents, but significant differences were not found in following a 
provider’s recommendation or following USPSTF guidelines.  This finding suggests that 
while many previous studies focused on the need to encourage aspirin use in primary 
prevention, more awareness for aspirin therapy is still necessary for both primary and 
secondary prevention.   USPSTF guidelines recommend that 63.1% of the respondents 
follow a daily aspirin regimen, but only 39.3% reported using aspirin therapy.  The 
benefits of aspirin in secondary prevention have been well-established, and the benefits 
for primary prevention have recently been demonstrated, so the lack of utilization of 
this treatment suggests an area of concern. 
 Perception of cardiovascular disease risk had a significant impact on the use of 
aspirin therapy.  Respondents with a high perceived risk of cardiovascular disease were 
more likely to use aspirin therapy than respondents with a low perceived risk.  While 
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limited research exists on the influence of perception of risk on the use of preventive 
medicine, this finding can be explained by the Health Belief Model.  The greater a 
person’s perceived risk of contracting a condition, the more likely they are to take 
preventive action.  These findings support further research into the effect of perception 
of risk on preventive action. 
 The influence a healthcare provider can have over his/her patient and the ability 
to support preventive medicine was also demonstrated through this study.  
Respondents were more likely to follow a provider’s recommendation than they were to 
be following USPSTF guidelines for aspirin use.  Healthcare providers provide cues for 
preventative action, and can influence perceived benefits and risks by giving their 
patient research-backed information.  Results suggest that healthcare providers may be 
able to close many demographic and socioeconomic disparities in aspirin use. 
 
Limitations 
 Several factors were not accounted for in the data analysis.  Many secondary 
prevention individuals may have not been on aspirin because they were on another 
medication to help thin their blood, or they were allergic to aspirin.  While data for 
these occurrences was obtained, it was not factored into the analysis.  Further 
examination of the data may provide insight into the lack of aspirin use by secondary 
prevention individuals.  In addition, the survey was distributed as a convenience sample, 
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so there may have been inherent error in the sample population.  Research suggests 
that many of the socioeconomic and demographic categories may be interrelated, so 
further analysis into specific correlations between these groups may provide more 
specific groups of individuals that could benefit from aspirin intervention programs 
(Rolka et al. 2001). 
 
Conclusion 
 Aspirin therapy has been shown to be an effective treatment for the prevention 
of myocardial infarction in men and strokes in women, both for primary and secondary 
prevention.  Yet, disparities exist in its use along demographic and socioeconomic lines.  
While previous research examined the use of aspirin and associated benefits, this study 
examined the use of aspirin compared to a healthcare provider’s recommendation and 
its use in accordance to established guidelines.  Findings in these categories suggest that 
while many researchers are focused on narrowing the disparities in aspirin use, all 
studied groups used aspirin therapy at a less-than-ideal rate.  In particular, men used 
aspirin at a greater rate than women, but followed USPSTF guidelines for its use at a far 
lower rate.  Both men and women may benefit from different types of intervention 
programs.  The lack of large disparities in aspirin use among racial and socioeconomic 
categories as found in existing literature suggest that a primary source of socioeconomic 
disparities may lie in access to quality, evidence-based medical care.   Respondents 
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followed the recommendation of their health care provider at a much greater rate than 
they followed the proper guidelines for use, suggesting that healthcare providers hold a 
vastly important role in the encouragement and use of aspirin therapy.  Overall, 
disparities exist in daily aspirin use, treatment, and proper use, and data suggests that 
each of these factors may be important in determining the effective use of aspirin by 
individuals that may gain the most benefit from aspirin therapy. 
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Table 1:  Demographic Characteristics of Respondents 
 
 
1:
 
 Valid % removes missing data and characteristics not factored into calculations. 
 
Characteristic Frequency    %  Valid %1 
Total Surveyed     100   917     100 
Gender    
    Men 332 36.2 36.2 
    Women 584 63.7 63.8 
Race     
    White 597 65.1 70.4 
    Black     27.4   251     29.6 
Age (years)    
    40 - 54 486 53.0 53.0 
    55 - 64 282 30.8 30.8 
    65 - 80 149 16.2 16.2 
Education    
    11th 87  Grade or Less 9.5 9.6 
    High School Graduate / GED 209 22.8 23.1 
    Some College 200 21.8 22.1 
    Associate’s Degree 62 6.8 6.9 
    Bachelor’s Degree 198 21.6 21.9 
    Master’s Degree 148 16.1 16.4 
Income    
    Less than $15,000 214 23.3 25.0 
    $15,000 - $23,999 111 12.1 13.0 
    $24,000 - $49,999 219 23.9 25.6 
    $50,000 - $75,000 151 16.5 17.7 
    More than $75,000 160 17.4 18.7 
    Less than $24,000 325 35.4 38.0 
    $24,000 or Greater 530 57.8 62.0 
Health Insurance    
    Medicaid / Care Source 127 13.8 14.3 
    Medicare 173 18.9 19.5 
    Private Insurance 562 61.3 63.3 
    Self-Pay / None 26 2.8 2.9 
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Table 2:  Effect of Demographic and Socioeconomic Characteristics on the Use of Daily 
Aspirin Therapy 
 
1:
 
 Respondent’s perceived risk of having a heart attack or stroke within the next 10 years. 
 
 
Characteristic % Daily Aspirin Use (N)       Χ P value 2 
Total     39.3 (358)   
Gender    
    Men 44.6 (146) 6.025 .009 
    Women 36.4 (212)   
Race     
    White 38.3 (228) .713 .221 
    Black       41.4 (103)  
Age (years)    
    40 - 54 26.5 (128)   
    55 - 64 48.4 (136) 80.351 < .0005 
    65 - 80 63.9 (94)   
Education    
    11th 33.3 (29)  Grade or Less   
    High School Graduate / GED 44.2 (92)   
    Some College 41.0 (82) 5.110 .403 
    Associate’s Degree 41.9 (26)   
    Bachelor’s Degree 36.2 (71)   
    Master’s Degree 36.5 (54)   
Income    
    Less than $24,000 44.6 (144) 6.318 .007 
    $24,000 or Greater 35.9 (190)   
Health Insurance    
    Medicaid / Care Source 42.1 (53)   
    Medicare 57.8 (100) 31.723 < .0005 
    Private Insurance 33.9 (190)   
    Self-Pay / None 38.5 (10)   
Prevention Category    
    Primary 30.0 (200) 89.161 < .0005 
    Secondary 64.5 (158)   
Perceived Risk  1   
    Low Risk (Less than 6%) 33.2 (125)   
    Medium Risk (6% to 10%) 41.6 (150) 10.534 .005 
    High Risk (Greater than 10%) 47.7 (62)   
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Table 3:  Effect of Demographic and Socioeconomic Characteristics Following Provider 
Recommendation to Use / Not Use Aspirin Therapy 
 
1:
 
 Respondent’s perceived risk of having a heart attack or stroke within the next 10 years. 
 
 
Characteristic % Daily Aspirin Use (N)       Χ P value 2 
Total      84.2 (691)   
Gender    
    Men 84.1 (243) .001 .523 
    Women 84.2 (447)   
Race     
    White 85.9 (474) 4.123 .029 
    Black       79.9 (171)  
Age (years)    
    40 - 54 86.6 (374)   
    55 - 64 83.5 (213) 6.276 .043 
    65 - 80 77.6 (104)   
Education    
    11th 80.3 (61)  Grade or Less   
    High School Graduate / GED 84.7 (150)   
    Some College 83.0 (151) 4.012 .548 
    Associate’s Degree 80.0 (44)   
    Bachelor’s Degree 88.1 (163)   
    Master’s Degree 83.7 (118)   
Income    
    Less than $24,000 84.5 (235) .003 .522 
    $24,000 or Greater 84.4 (416)   
Health Insurance    
    Medicaid / Care Source 81.9 (86)   
    Medicare 81.1 (129) 2.904 .407 
    Private Insurance 85.6 (441)   
    Self-Pay / None 78.3 (18)   
Prevention Category    
    Primary 84.7 (511) .568 .257 
    Secondary 82.6 (180)   
Perceived Risk  1   
    Low Risk (Less than 6%) 86.4 (293)   
    Medium Risk (6% to 10%) 81.6 (266) 2.937 .230 
    High Risk (Greater than 10%) 83.2 (99)   
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Table 4:  Effect of Demographic and Socioeconomic Characteristics on the Appropriate 
Use of Daily Aspirin Therapy in Accordance with USPSTF Guidelines
 
2 
1: Respondent’s perceived risk of having a heart attack or stroke within the next 10 years. 
2:
Characteristic 
 USPSTF Guidelines listed in Figure 1. 
 
% Daily Aspirin Use (N)       Χ P value 2 
Total     63.1 (491)   
Gender    
    Men 54.2 (160) 16.070 < .001 
    Women 68.5 (331)   
Race     
    White 64.5 (324) 1.195 .156 
    Black       60.3 (132)  
Age (years)    
    40 - 54 64.3 (250)   
    55 - 64 61.5 (155) 0.508 .776 
    65 - 80 62.8 (86)   
Education    
    11th 57.1 (44)  Grade or Less   
    High School Graduate / GED 58.4 (104)   
    Some College 62.8 (108) 7.086 .214 
    Associate’s Degree 66.7 (34)   
    Bachelor’s Degree 69.4 (120)   
    Master’s Degree 67.8 (80)   
    High School Degree or Less 58.0 (148) 5.324 .013 
    Some College / College Degree 66.5 (342)   
Income    
    Less than $24,000 62.0 (171) 1.275 .147 
    $24,000 or Greater 66.1 (300)   
Health Insurance    
    Medicaid / Care Source 59.0 (62)   
    Medicare 63.8 (95) 1.630 .653 
    Private Insurance 64.2 (312)   
    Self-Pay / None 73.3 (11)   
Prevention Category    
    Primary 62.4 (333) .412 .288 
    Secondary 64.8 (158)   
Perceived Risk  1   
    Low Risk (Less than 6%) 62.5 (198)   
    Medium Risk (6% to 10%) 65.0 (199) .687 .709 
    High Risk (Greater than 10%) 61.3 (73)   
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Figure 1:  United States Preventative Services Task Force Guidelines for Primary 
Prevention Aspirin Therapy
 
1 
1: Guidelines indicate that all secondary prevention patients take daily aspirin.   
2:
 
 CHD = Coronary Heart Disease.  Percentage risks indicate the risk level at which the possible benefit of 
cardiovascular disease prevention balances with the risk of serious bleeding events.  For purposes of study, CHD risk 
and stroke risk are approximated using Framingham risk assessment tool. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Men (age): 10-Year CHD Risk2    Women (age): : 10-Year Stroke Risk: 
       < 45 years   < 55 years      Do not take       Do not take 
       45-59 years      ≥ 4% risk   55-59 years       ≥ 3% risk 
       60-69 years      ≥ 9% risk   60-69 years       ≥ 8% risk 
       70-79 years      ≥ 12% risk   70-79 years       ≥ 11% risk 
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Figure 2:  The Health Belief Model
 
1 
1:
 
 National Cancer Institute Publication, 2005. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concept: Definition:   
    Perceived Susceptibility     Beliefs about the chances of getting a condition.   
    Perceived Severity      Beliefs about the seriousness of a condition and its consequences.  
    Perceived Benefits     Beliefs about the effectiveness of taking action to reduce risk or seriousness.   
    Perceived Barriers     Beliefs about the material and psychological costs of taking action.   
    Cues to Action     Factors that activate “readiness to change”.   
    Self-efficacy     Confidence in one’s ability to take action.   
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Figure 3: Gender Differences in the Use of Aspirin Therapy1,2,3 
 
1: Using daily aspirin therapy, p = < 0.01 
2: Following provider recommendation, p = 0.52 
3:
 
 Appropriately using aspirin therapy (USPSTF guidelines), p = < 0.01 
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